Odabas H - Search Results

1

Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy.

Akdag G, Dogan A, Yildirim S, Kinikoglu O, Mokresh ME, Alomari O, Turkoglu E, Isik D, Sürmeli H, Basoglu T, Sever ON, Odabas H, Yildirim ME, Turan N. Akdag G, et al. Among authors: odabas h. Cureus. 2024 Jun 28;16(6):e63362. doi: 10.7759/cureus.63362. eCollection 2024 Jun. Cureus. 2024. PMID: 39070363 Free PMC article.

2

Is there any effect of first-day usage of a totally implantable venous access device on complications?

Karanlik H, Odabas H, Yildirim I, Ozgur I, Kilic B, Sen F, Kurul S, Aydiner A. Karanlik H, et al. Among authors: odabas h. Int J Clin Oncol. 2015 Dec;20(6):1057-62. doi: 10.1007/s10147-015-0830-7. Epub 2015 Apr 25. Int J Clin Oncol. 2015. PMID: 25911604

3

Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative study.

Tugba Kos F, Aksoy S, Odabas H, Ozdemir N, Oksuzoglu B, Uncu D, Zengin N. Tugba Kos F, et al. Among authors: odabas h. J BUON. 2011 Jul-Sep;16(3):464-8. J BUON. 2011. PMID: 22006751

4

First-line therapy for metastatic colorectal carcinoma: modified FOLFOX4 or FOLFIRI-bevacizumab.

Odabas H, Ozdemir N, Abali H, Oksuzoglu B, Isik M, Uncu D, Cihan S, Seker M, Zengin N. Odabas H, et al. J BUON. 2011 Apr-Jun;16(2):247-52. J BUON. 2011. PMID: 21766493

5

Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer.

Kos FT, Uncu D, Ozdemir N, Budakoglu B, Odabaş H, Abali H, Oksuzoglu B, Aksoy S, Zengin N. Kos FT, et al. Among authors: odabas h. Chemotherapy. 2011;57(3):230-5. doi: 10.1159/000327840. Epub 2011 May 18. Chemotherapy. 2011. PMID: 21597287

6

Gastric adenocarcinoma under the age of 40; more metastatic, less differentiated.

Isik M, Caner S, Metin Seker M, Civelek B, Odabas H, Ozdemir N, Uncu D, Zengin N. Isik M, et al. Among authors: odabas h. J BUON. 2011 Apr-Jun;16(2):253-6. J BUON. 2011. PMID: 21766494

7

Effect of port-care frequency on venous port catheter-related complications in cancer patients.

Odabas H, Ozdemir NY, Ziraman I, Aksoy S, Abali H, Oksuzoglu B, Isik M, Civelek B, Dede D, Zengin N. Odabas H, et al. Int J Clin Oncol. 2014 Aug;19(4):761-6. doi: 10.1007/s10147-013-0609-7. Epub 2013 Aug 27. Int J Clin Oncol. 2014. PMID: 23978939

8

Gemcitabine and cisplatin in patients with carcinoma of unknown primary site.

Isik M, Seker MM, Odabas H, Kos FT, Uncu D, Zengin N. Isik M, et al. Among authors: odabas h. Med Oncol. 2011 Jun;28(2):591-6. doi: 10.1007/s12032-010-9465-8. Epub 2010 Mar 19. Med Oncol. 2011. PMID: 20300978

9

Long term survival in a metastatic alveolar soft part sarcoma at the time of diagnosis: a case with 17 years of follow-up.

Kos FT, Uncu D, Oksuzoglu B, Aksoy S, Ozdemir N, Odabas H, Isik M, Civelek B, Zengin N. Kos FT, et al. Among authors: odabas h. J BUON. 2011 Apr-Jun;16(2):376-7. J BUON. 2011. PMID: 21766518 No abstract available.

10

Adjuvant modified FOLFOX-4 in patients with stage III rectum adenocarcinoma.

Cihan Ş, Uncu D, Babacan NA, Özdemir N, Odabaş H, Aksoy S, Öksüzoğlu B, Zengin N. Cihan Ş, et al. Among authors: odabas h. Asian Pac J Cancer Prev. 2011;12(4):967-70. Asian Pac J Cancer Prev. 2011. PMID: 21790235 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters